Carmignac Gestion’s Apellis Pharmaceuticals APLS Stock Holding History

Carmignac Gestion’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-35,127	Closed	-$1.41M	–	100
2026 Q1	$1.41M	Buy	+35,127	New	+$757K	0.02%	87

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carmignac Gestion's APLS Position: Q2 2026 in Review

Carmignac Gestion sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 35,127 shares — an estimated $1.41M sold.

Carmignac Gestion first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $1.41M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Carmignac Gestion reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Carmignac Gestion sold 35,127 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.41M.
Carmignac Gestion first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Carmignac Gestion's Apellis Pharmaceuticals position peaked at $1.41M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.